Amneal Pharmaceuticals, Inc. AMRX Repayments Of Long Term Debt, Revolving Credit Facility And Financing Lease Obligations
Repayments Of Long Term Debt, Revolving Credit Facility And Financing Lease Obligations at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept amrx:RepaymentsOfLongTermDebtRevolvingCreditFacilityAndFinancingLeaseObligations.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s repayments of long term debt, revolving credit facility and financing lease obligations.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s repayments of long term debt, revolving credit facility and financing lease obligations?
- Amneal Pharmaceuticals, Inc. (AMRX) reported repayments of long term debt, revolving credit facility and financing lease obligations of $140.84M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s repayments of long term debt, revolving credit facility and financing lease obligations changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s repayments of long term debt, revolving credit facility and financing lease obligations decreased by 40.2% year-over-year, from $235.53M to $140.84M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s repayments of long term debt, revolving credit facility and financing lease obligations?
- Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s repayments of long term debt, revolving credit facility and financing lease obligations has grown at a 183.6% compound annual growth rate (CAGR), from -$123.27M to -$2.81B.
- What does repayments of long term debt, revolving credit facility and financing lease obligations mean?
- This represents the cash used to reduce the principal balance of long-term debt, revolving credit facilities, and financing lease obligations. It is a key indicator of the company's commitment to deleveraging and managing its capital structure.